Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Myelodysplastic Syndromes 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Myeloid, Acute 2Prostatic Neoplasms 1Neoplasm, Residual 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Biphenotypic, Acute 1Leukemia 1Congenital Abnormalities 1Blast Crisis 1

Interventions

fludarabine phosphate 28Peripheral Blood Stem Cell Transplantation 25Cyclophosphamide 24Whole-Body Irradiation 22Busulfan 22Tacrolimus 19Mycophenolic Acid 19Methotrexate 15Antilymphocyte Serum 13Cyclosporine 12Melphalan 9Filgrastim 9Cytarabine 9Etoposide 8Cord Blood Stem Cell Transplantation 7fludarabine 6Thiotepa 6Methylprednisolone 6Imatinib Mesylate 5Granulocyte Colony-Stimulating Factor 5thymoglobulin 4merphos 4Sirolimus 4Rituximab 4Radiotherapy 4Flow Cytometry 4Dexamethasone 4Dasatinib 4Cyclosporins 4Calcium Dobesilate 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Blast Crisis × treosulfan × Clear all
NCT00860574 2021-06-22

Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia

Fred Hutchinson Cancer Center

Phase 2 Completed
96 enrolled 15 charts
LymphoidOther hematologic neoplasm

Congenital Abnormalities, Blast Crisis, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡